A novel vaccine candidate could offer broad protection against fentanyl and its many illicit variants. By training the immune system to recognize a shared molecular signature, the breakthrough approach outpaces the rapid development of synthetic designer opioids.
A new study published in the Journal of Medicinal Chemistry suggests that a novel vaccine candidate can protect against fentanyl and its many illicit variants by training the immune system to recognize a broad molecular signature rather than a single... [9120 chars]